![Nataskia Lampe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Nataskia Lampe worked as an Associate Director of Regulatory Affairs at Lung Biotechnology PBC.
She then worked at AbbVie, Inc. as an Asset Strategy Leader for Neuroscience & Fibrosis from 2018 to 2021.
In 2021, she became the Vice President & Head of Regulatory Affairs at Pieris Pharmaceuticals, Inc. Ms. Lampe received her undergraduate degree from Tulane University School of Medicine and her graduate degree from Thomas Jefferson University.
Precedenti posizioni note di Nataskia Lampe
| Società | Posizione | Fine |
|---|---|---|
| PIERIS PHARMACEUTICALS | Consigliere Generale | 01/08/2022 |
| ABBVIE INC. | Corporate Officer/Principal | 01/08/2021 |
Lung Biotechnology PBC
 Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Consigliere Generale | - |
Formazione di Nataskia Lampe
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
31
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Lung Biotechnology PBC
Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Tulane University School of Medicine
 Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
